New insights into the cardiac natriuretic peptides.
Bonow
R O
RO
D009320:Atrial Natriuretic Factor / Q000097:blood / Q000502:physiology*; D005260:Female; D006162:Guanylate Cyclase / Q000378:metabolism; D006333:Heart Failure / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000097:blood / Q000150:complications / Q000401:mortality; D020097:Natriuretic Peptide, Brain; D009419:Nerve Tissue Proteins / Q000097:blood / Q000502:physiology* / Q000627:therapeutic use; D005082:Physical Exertion; D011379:Prognosis; D017461:Receptors, Atrial Natriuretic Factor / Q000502:physiology; D018570:Risk Assessment; D013318:Stroke Volume; D018487:Ventricular Dysfunction, Left / Q000097:blood / Q000503:physiopathology*
D009419:Nerve Tissue Proteins; C058930:brain natriuretic peptide receptor; D020097:Natriuretic Peptide, Brain; D009320:Atrial Natriuretic Factor; D006162:Guanylate Cyclase; D017461:Receptors, Atrial Natriuretic Factor